Received Apr 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
missed her 2nd dose, and is almost time for her 3rd dose of Twinrix"; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 83-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (1st dose received on 16-SEP-2024, batch number-344J3 and expiry date 12-SEP-2026). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: missed her 2nd dose, and is almost time for her 3rd dose of Twinrix"). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-MAR-2025 The patient that missed her 2nd dose, and was almost time for her 3rd dose of Twinrix. Till the time of reporting the patient had not received the second dose of Twinrix, which led to incomplete course of vaccination. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.